Amgen’s new NC site will use traditional drug substance technologies and Amgen’s latest innovations to create a hybrid facility, called FleXBatch, according to a company official, who explained that this technique makes drug substance manufacturing more efficient and will help Amgen achieve its company-wide sustainability goals of reducing water use by 40%, cutting waste disposal by 75% and becoming carbon neutral by the year 2027.